FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313415092> ?p ?o ?g. }

• W4313415092 endingPage "12" @default.
• W4313415092 startingPage "6" @default.
• W4313415092 abstract "Objective — to study the clinical effectiveness of chemotherapy using bedaquiline (Bdq) and delamanid (Dlm) in children and adolescents with multidrug-resistant (MDR) and extensive drug resistant (XDR) pulmonary tuberculosis of lungs (TBL).&#x0D; Materials and methods. A retrospective cohort analysis of the medical records of 40 patients with pulmonary tuberculosis (TB) with MDR/XDR was conducted in order to study the clinical effectiveness of chemotherapy with Bdq and Dlm. Among 40 patients were 25 (62.5 %) children aged 0 to 14 years and 15 (37.5 %) — teenagers aged 15 to 17; there were 18 (47.5 %) boys, 22 (52.5 %) girls. The patients were divided into two groups: the first group — 25 children and the second group — 15 teenagers. Microbiological research in children and adolescents included: detection of Mycobacterium tuberculosis (MTB) in sputum by smear microscopy, sowing of material on Levenstein—Jensen medium, typing of isolated mycobacteria on BACTEC MGIT 960, determination of the drug susceptibility test of strains of MTB to antituberculosis drugs (ATBDs) of first- and second-line, as well as molecular genetic research of sputum, in particular by GeneXpert MTB/RIF/Ultra and linear probe analysis. All children and adolescents received an individualized treatment regimen depending on the resistance of MTB to ATBDs or on the resistance of MTB at the source of infection.&#x0D; Results and discussion. Among the examined children (25), who were prescribed Bdq and Dlm, almost half (44.0 %) were aged from 0 to 4 years, 12.0 % — from 5 to 8 years and 44.0 % — from 9 to 14 years. Patients aged 17 years (46.7 %) prevailed among teenagers (15). MDR/RIF-TB was diagnosed in 10 (40.0%), XDR-TB determined in 3 (12.0 %) and risk of MDR-TB (RMDR-TB) — in 12 (48.0 %) children who were prescribed a new treatment regimen with Bdq and Dlm. At the same time, MDR-TB diagnosed 1.7 times more often, XDR-TB 2.8 times more often and RMDR-TB 3.3 times less often among adolescents compared to children.The primary tuberculous complex found in 12 (48.0 %) children, TB damage of lung and bone — in 4 (16.0 %), TB of the intrathoracic lymph nodes — in 3 (12.0 %), TB of the lungs and central nervous system — in 2 (8.0 %) and infiltrative TB of the lungs — in 3 (12.0 %). The infiltrative pulmonary TB was observed 7.5 times more often and the disseminated form 3.3 times more often in adolescents than in children.All children didn’t excretion of MTB after the two months of treatment with Bdq and Dlm. However, non-bacterial excretion in all adolescents was achieved within 3 months of chemotherapy (CT). Significant positive X-ray dynamics were found in 23 (92.0 %) children and 12 (80.0 %) adolescents during 9 months of CT. Lung changes remained in 2 (8.0 %) children and 3 (20.0 %) adolescents after 9 months of treatment. However, in both children and adolescents resolution of infiltration, densification of focies and formation of fibrosis in the lungs were confirmed radiologically at the end of the course of treatment.&#x0D; Conclusions. Among 21 (84.0%) children and 10 (66.7 %) adolescents were cured at the end of the course of complex treatment with the use of Bdq and Dlm. Treatment was completed 2 times more often in adolescents than in children (33.3 vs. 16.0 %, p < 0.05). The success of the treatment at the occurrence of new ATBDs was established in all children and adolescents. In addition, among 84.0 % children and 73.3 % adolescents the treatment ended with the formation of small residual changes." @default.
• W4313415092 created "2023-01-06" @default.
• W4313415092 creator A5016324949 @default.
• W4313415092 creator A5016405026 @default.
• W4313415092 creator A5017242247 @default.
• W4313415092 creator A5023755105 @default.
• W4313415092 creator A5035861718 @default.
• W4313415092 creator A5035938438 @default.
• W4313415092 creator A5058622903 @default.
• W4313415092 creator A5059168184 @default.
• W4313415092 creator A5062452726 @default.
• W4313415092 creator A5072319553 @default.
• W4313415092 creator A5082025250 @default.
• W4313415092 creator A5082393048 @default.
• W4313415092 date "2022-12-05" @default.
• W4313415092 modified "2023-10-18" @default.
• W4313415092 title "Clinical effectiveness of bedaquilin and delamanid treatment of children and adolescents with drug-­resistant tuberculosis" @default.
• W4313415092 doi "https://doi.org/10.30978/tb2022-4-6" @default.
• W4313415092 hasPublicationYear "2022" @default.
• W4313415092 type Work @default.
• W4313415092 citedByCount "0" @default.
• W4313415092 crossrefType "journal-article" @default.
• W4313415092 hasAuthorship W4313415092A5016324949 @default.
• W4313415092 hasAuthorship W4313415092A5016405026 @default.
• W4313415092 hasAuthorship W4313415092A5017242247 @default.
• W4313415092 hasAuthorship W4313415092A5023755105 @default.
• W4313415092 hasAuthorship W4313415092A5035861718 @default.
• W4313415092 hasAuthorship W4313415092A5035938438 @default.
• W4313415092 hasAuthorship W4313415092A5058622903 @default.
• W4313415092 hasAuthorship W4313415092A5059168184 @default.
• W4313415092 hasAuthorship W4313415092A5062452726 @default.
• W4313415092 hasAuthorship W4313415092A5072319553 @default.
• W4313415092 hasAuthorship W4313415092A5082025250 @default.
• W4313415092 hasAuthorship W4313415092A5082393048 @default.
• W4313415092 hasBestOaLocation W43134150921 @default.
• W4313415092 hasConcept C114851261 @default.
• W4313415092 hasConcept C126265401 @default.
• W4313415092 hasConcept C126322002 @default.
• W4313415092 hasConcept C142724271 @default.
• W4313415092 hasConcept C187212893 @default.
• W4313415092 hasConcept C2776301714 @default.
• W4313415092 hasConcept C2776409635 @default.
• W4313415092 hasConcept C2776962512 @default.
• W4313415092 hasConcept C2777975735 @default.
• W4313415092 hasConcept C2779912665 @default.
• W4313415092 hasConcept C2780544761 @default.
• W4313415092 hasConcept C2780867798 @default.
• W4313415092 hasConcept C2781069245 @default.
• W4313415092 hasConcept C2781413609 @default.
• W4313415092 hasConcept C71924100 @default.
• W4313415092 hasConcept C86803240 @default.
• W4313415092 hasConcept C89423630 @default.
• W4313415092 hasConceptScore W4313415092C114851261 @default.
• W4313415092 hasConceptScore W4313415092C126265401 @default.
• W4313415092 hasConceptScore W4313415092C126322002 @default.
• W4313415092 hasConceptScore W4313415092C142724271 @default.
• W4313415092 hasConceptScore W4313415092C187212893 @default.
• W4313415092 hasConceptScore W4313415092C2776301714 @default.
• W4313415092 hasConceptScore W4313415092C2776409635 @default.
• W4313415092 hasConceptScore W4313415092C2776962512 @default.
• W4313415092 hasConceptScore W4313415092C2777975735 @default.
• W4313415092 hasConceptScore W4313415092C2779912665 @default.
• W4313415092 hasConceptScore W4313415092C2780544761 @default.
• W4313415092 hasConceptScore W4313415092C2780867798 @default.
• W4313415092 hasConceptScore W4313415092C2781069245 @default.
• W4313415092 hasConceptScore W4313415092C2781413609 @default.
• W4313415092 hasConceptScore W4313415092C71924100 @default.
• W4313415092 hasConceptScore W4313415092C86803240 @default.
• W4313415092 hasConceptScore W4313415092C89423630 @default.
• W4313415092 hasIssue "4" @default.
• W4313415092 hasLocation W43134150921 @default.
• W4313415092 hasOpenAccess W4313415092 @default.
• W4313415092 hasPrimaryLocation W43134150921 @default.
• W4313415092 hasRelatedWork W1987247410 @default.
• W4313415092 hasRelatedWork W2112022845 @default.
• W4313415092 hasRelatedWork W2386257009 @default.
• W4313415092 hasRelatedWork W2441872429 @default.
• W4313415092 hasRelatedWork W2862367420 @default.
• W4313415092 hasRelatedWork W2895817599 @default.
• W4313415092 hasRelatedWork W2911690370 @default.
• W4313415092 hasRelatedWork W2983049979 @default.
• W4313415092 hasRelatedWork W3165151283 @default.
• W4313415092 hasRelatedWork W4385568009 @default.
• W4313415092 isParatext "false" @default.
• W4313415092 isRetracted "false" @default.
• W4313415092 workType "article" @default.